Goldman Sachs Group Inc Pliant Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 347,397 shares of PLRX stock, worth $4.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
347,397
Previous 213,238 62.92%
Holding current value
$4.62 Million
Previous $2.29 Million 69.9%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$10.52 - $14.35 $1.41 Million - $1.93 Million
134,159 Added 62.92%
347,397 $3.89 Million
Q2 2024

Aug 13, 2024
SELL
$10.58 - $15.61 $3.06 Million - $4.52 Million
-289,333 Reduced 57.57%
213,238 $2.29 Million
Q1 2024

May 15, 2024
BUY
$14.14 - $19.59 $1.63 Million - $2.26 Million
115,325 Added 29.78%
502,571 $7.49 Million
Q4 2023

Feb 13, 2024
BUY
$12.85 - $19.15 $2.85 Million - $4.25 Million
222,132 Added 134.53%
387,246 $7.01 Million
Q3 2023

May 14, 2024
SELL
$14.58 - $20.15 $3.24 Million - $4.48 Million
-222,132 Reduced 57.36%
165,114 $2.86 Million
Q3 2023

Nov 14, 2023
SELL
$14.58 - $20.15 $888,053 - $1.23 Million
-60,909 Reduced 26.95%
165,114 $2.86 Million
Q2 2023

May 14, 2024
SELL
$18.12 - $30.56 $679,318 - $1.15 Million
-37,490 Reduced 14.23%
226,023 $4.1 Million
Q2 2023

Aug 14, 2023
SELL
$18.12 - $30.56 $679,318 - $1.15 Million
-37,490 Reduced 14.23%
226,023 $4.1 Million
Q1 2023

May 14, 2024
BUY
$18.73 - $36.26 $2.18 Million - $4.21 Million
116,156 Added 78.83%
263,513 $7.01 Million
Q1 2023

May 11, 2023
BUY
$18.73 - $36.26 $2.18 Million - $4.21 Million
116,156 Added 78.83%
263,513 $7.01 Million
Q4 2022

May 14, 2024
BUY
$17.0 - $25.43 $761,447 - $1.14 Million
44,791 Added 43.67%
147,357 $2.85 Million
Q4 2022

Feb 13, 2023
BUY
$17.0 - $25.43 $761,447 - $1.14 Million
44,791 Added 43.67%
147,357 $2.85 Million
Q3 2022

May 14, 2024
SELL
$7.67 - $24.23 $2.52 Million - $7.96 Million
-328,658 Reduced 76.22%
102,566 $2.14 Million
Q3 2022

Nov 10, 2022
SELL
$7.67 - $24.23 $2.52 Million - $7.96 Million
-328,658 Reduced 76.22%
102,566 $2.14 Million
Q2 2022

May 14, 2024
BUY
$4.11 - $8.75 $180,749 - $384,807
43,978 Added 11.36%
431,224 $3.45 Million
Q2 2022

Aug 15, 2022
BUY
$4.11 - $8.75 $1.19 Million - $2.52 Million
288,539 Added 202.22%
431,224 $3.45 Million
Q1 2022

May 16, 2022
BUY
$7.01 - $14.1 $315,849 - $635,303
45,057 Added 46.15%
142,685 $1 Million
Q4 2021

Feb 14, 2022
BUY
$12.27 - $18.26 $792,175 - $1.18 Million
64,562 Added 195.25%
97,628 $1.32 Million
Q3 2021

Nov 10, 2021
BUY
$16.48 - $28.98 $544,927 - $958,252
33,066 New
33,066 $558,000

Others Institutions Holding PLRX

# of Institutions
168
Shares Held
63.2M
Call Options Held
245K
Put Options Held
373K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $647M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email